China Diabetes Devices and Therapeutics Business Opportunities Databook - Q2 2023 Update

According to the publisher, China diabetes devices market size is expected to record a CAGR of 10.3% during 2023-2027 to reach US$10.051 billion by 2027, increasing from US$6.154 billion in 2023. Over the last five years, the sector has recorded a CAGR of 11.6% to reach US$5.513 billion in 2022.

This report provides an in-depth data-centric analysis of the emerging opportunities in the diabetes devices and therapeutics industry. It covers a detailed view of market size and forecast across various segments such as by category, diagnosis and monitoring devices, therapeutics, route of administration, type of diabetes, distribution channels, and end users.

This section is a part of the title “Global Diabetes Devices and Therapeutics Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, and Competitive Landscape - Q2 2023 Update”.

Scope

This report provides an in-depth, data-centric analysis of the China diabetes devices and therapeutics market 2018-2027. Below is a summary of key market segments:

Diabetes Devices and Therapeutics Market Share by Category

• Diagnosis and Monitoring Devices
• Therapeutics

Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices

• Blood Glucose Monitoring Devices
• Insulin Delivery Devices
• Diabetes Management and Mobile Applications
• Artificial Pancreas Devices

Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices

• Self-Monitoring Blood Glucose Devices
• Continuous Blood Glucose Monitoring Devices
• Test Strips
• Lancets

Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices

• Insulin Pumps
• Insulin Pens
• Insulin Syringes

Diabetes Devices and Therapeutics Market Share by Therapeutics

• Oral Anti-Diabetic Drugs
• Insulin
• Non-Insulin Injectable Drugs
• Combination Drugs

Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs

• Alpha-Glucosidase Inhibitors
• DPP-4 Inhibitors
• SGLT-2 Inhibitors

Diabetes Devices and Therapeutics Market Share by Insulin

• Basal or Long-Acting
• Bolus or Fast-Acting
• Traditional Human Insulin Drugs
• Insulin Biosimilars

Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs

• GLP-1 Receptor Agonists
• Amylin Analogue

Diabetes Devices and Therapeutics Market Share by Combination Drugs

• Combination Insulin
• Oral Combination

Diabetes Devices and Therapeutics Market Share by Route of Administration

• Subcutaneous
• Intravenous
• Others

Diabetes Devices and Therapeutics Market Share by Type of Diabetes

• Type 1 Diabetes
• Type 2 Diabetes

Diabetes Devices and Therapeutics Market Share by Distribution Channels

• Online Pharmacies
• Hospital Pharmacies
• Retail Pharmacies

Diabetes Devices and Therapeutics Market Share by End User

• Hospitals
• Diabetes Clinics
• Homecare

Reasons to buy

• In-depth understanding of diabetes devices and therapeutics market dynamics: Understand market opportunity, industry dynamics, key trends, and drivers across different market segments and sub-segments of the industry in China.
• Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.
• Get market share analysis by end users: Get a detailed analysis across different end users such as hospitals, diabetes clinics, and homecare within the China.